ResMed announces availability of home sleep apnea test NightOwl
Resmed (RMD) announced its home sleep apnea test, NightOwl, is now available across the United States. NightOwl is an FDA-cleared home sleep ...
ResMed Inc. stock falls Thursday, still outperforms market
ResMed Inc. closed 18.89% short of its 52-week high of $263.05, which the company reached on January 30th.
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...